Contract W911QY12C0076
Texas Biomedical Research Institute · Department Of Defense · June 1, 2012
Texas Biomedical Research Institute was awarded a federal contract by Department Of Defense (Department Of The Army) on June 1, 2012 for $8.85 million of work in research and development in biotechnology. Performance is in San Antonio, TX. It was awarded under full and open competition. The contract has been modified 9 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on January 28, 2015.
Contract details
- PIID
- W911QY12C0076
- Award type
- Dca
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541711 · Research And Development In Biotechnology
- Product / service
- R&D- Defense Other: Services (Applied Research/Exploratory Development)
- Place of performance
- San Antonio, TX
- First action
- June 1, 2012
- Latest action
- January 28, 2015
Description
ZEBOV NON VACCINE CHALLANGE
Modification timeline
-
January 28, 2015Mod P00009$0
-
November 17, 2014Mod P00008$0
-
September 24, 2014Mod P00007$0
-
April 22, 2014Mod P00006$3.83M
-
February 21, 2014Mod P00005$1.14M
-
September 16, 2013Mod P00004$1.49M
-
August 29, 2013Mod P00003CYNO MACAQUES$0
-
July 29, 2013Mod P00002CYNO MACAQUES$0
-
May 1, 2013Mod P00001CYNO MACAQUES$0
-
June 1, 2012Base awardIN VITRO AND IN VIVO CHARACTERIZATION OF FILOVIRUS.$2.40M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bluehalo, Llc | Department Of Defense | November 4, 2025 | $0 |
| Bluehalo, Llc | Department Of Defense | November 4, 2025 | $0 |
| Bluehalo, Llc | Department Of Defense | November 4, 2025 | $3.00M |
| Inbios International Inc | Department Of Defense | September 22, 2025 | $25.66M |
| Dynport Vaccine Company Llc | Department Of Defense | September 12, 2025 | $117.63M |
| Westat, Inc. | Department Of Defense | August 28, 2025 | $22.21M |
Top contractors in NAICS 541711
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Alliance For Energy Innovation, Llc | 2 | $10.68B |
| 2 | Emergent Product Development Gaithersburg Inc. | 7 | $1.63B |
| 3 | Janssen Pharmaceuticals, Inc. | 2 | $1.05B |
| 4 | Regeneron Pharmaceuticals Inc | 4 | $1.01B |
| 5 | Siga Technologies, Inc. | 3 | $560.59M |
| 6 | Battelle National Biodefense Institute, Llc | 106 | $469.31M |
| 7 | Glaxosmithkline, Llc | 6 | $321.65M |
| 8 | Merck Sharp & Dohme Llc | 3 | $309.72M |
| 9 | Sri International | 130 | $258.61M |
| 10 | American Type Culture Collection | 7 | $243.18M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract W911QY12C0076?
Contract W911QY12C0076 is a federal contract awarded to Texas Biomedical Research Institute by Department Of Defense on June 1, 2012 for $8.85 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 9 times since the base award.
Who won contract W911QY12C0076?
Texas Biomedical Research Institute won contract W911QY12C0076 from Department Of Defense.
How much is contract W911QY12C0076 worth?
Contract W911QY12C0076 has obligated $8.85 million to date.